Study S000310

A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT03287076
Acronym: TEXAIS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: SINGLE
Status: UNKNOWN
Enrollment: 350
Start: 2017-11-23
Primary completion: 2021-10-04
Lead sponsor: Neuroscience Trials Australia
Conditions: Acute Ischemic Stroke
Interventions: DRUG:Exenatide Injection
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: EUDRACT_NUMBER:2018-004325-88; NIH:2018

Registered primary outcomes

improved neurological outcome [7 days]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0007546	Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial. Bladin CF, Stroke	2023	Randomized trial	PMID 38011235 DOI	cites ClinicalTrials.gov:NCT03287076; registry reference DERIVED:38011235